A clinical study to analyze the safety and effectiveness of Intra Cath-2 (I.V Cannula) during infusion therapy in Indian populatio
- Conditions
- Health Condition 1: Z768- Persons encountering health services in other specified circumstances
- Registration Number
- CTRI/2021/03/031852
- Lead Sponsor
- Romsons Scientific and Surgical Industries Pvt Ltd
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 100
1.Males and Females above 18 year expected to require intravenous peripheral infusion therapy.
2.Subject who can provide informed consent form in writing and medically in a position to undergo consent and screening process.
3.The subject is willing and able to comply with the requirement of the follow-up.
1.Subject who present with medical emergency, where treatment is more priority than the informed consent process.
2.Subject, who cannot provide informed consent such as unconscious, mentally challenged subject, etc.
3.Allergy with any of the material of Intra Cath-2 (I.V Cannula) and its component.
4.Subject who is pregnant or breastfeeding.
5.Subject is of childbearing potential and has a positive pregnancy test since admission to the hospital.
6.Participation in another research study involving an active investigation within 30 days prior to consent.
Study & Design
- Study Type
- PMS
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method